In a special podcast interview with BioCentury’s Editor in Chief Simone Fishburn, James Sabry, Global Head of Pharma Partnering at Roche and Mike Gilman CEO of Arrakis discuss consummating this deal while under lockdown of COVID-19.

Special Report: Consummating a deal under lockdown

<p>BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.<br><br>For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.</p>

Business

Science

Life Sciences

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Share Special Report: Consummating a deal under lockdown

Sign up to save your podcasts

Special Report: Consummating a deal under lockdown

Special Report: Consummating a deal under lockdown

More shows like BioCentury This Week

Freakonomics Radio

Bloomberg Intelligence

Odd Lots

Nature Podcast

The Long Run with Luke Timmerman

The Readout Loud

Making Sense

Thoughts on the Market

Biotech 2050 Podcast

Business Of Biotech

MIT Technology Review Narrated

Biotech Hangout

WSJ's Take On the Week

The Top Line

The BioCentury Show